JW (Cayman) Therapeutics Co. Ltd (HKG:2126)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
2.260
-0.050 (-2.16%)
Feb 13, 2026, 4:08 PM HKT

HKG:2126 Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
9175189081,7415,33310,221
Market Cap Growth
72.92%-42.92%-47.87%-67.36%-47.83%-
Enterprise Value
616-7-461012,83112,303
Last Close Price
2.261.282.264.3513.4426.35
PS Ratio
4.713.084.7410.57141.07-
PB Ratio
0.920.420.490.651.562.51
P/TBV Ratio
1.700.830.851.052.203.24
EV/Sales Ratio
3.16--0.6174.89-
Debt / Equity Ratio
0.410.360.190.120.050.04
Net Debt / Equity Ratio
-0.30-0.29-0.41-0.47-0.60-0.73
Net Debt / EBITDA Ratio
1.020.871.411.762.295.52
Net Debt / FCF Ratio
1.351.001.691.812.666.51
Asset Turnover
0.110.080.070.050.01-
Inventory Turnover
1.342.452.292.431.35-
Quick Ratio
1.441.663.854.579.3111.14
Current Ratio
1.591.744.044.789.5311.17
Return on Equity (ROE)
-51.67%-41.40%-38.04%-32.89%-22.58%-133.78%
Return on Assets (ROA)
-12.23%-14.99%-14.43%-14.75%-13.99%-13.15%
Return on Capital Employed (ROCE)
-35.00%-37.80%-30.30%-28.10%-26.40%-13.20%
Earnings Yield
-73.82%-121.33%-93.23%-54.95%-16.17%-19.33%
FCF Yield
-24.23%-69.57%-49.87%-39.85%-14.60%-4.48%
Buyback Yield / Dilution
-0.58%-0.51%-0.35%-2.59%-203.07%-102.92%
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.